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Summary
Fullerenes are soccer ball-shaped molecules com-
posed of carbon atoms, and, when derivatized with
functional groups, they become soluble and can act
as photosensitizers. Antimicrobial photodynamic
therapy combines a nontoxic photosensitizer with
harmless visible light to generate reactive oxygen
species that kill microbial cells. We have compared
the antimicrobial activity of six functionalized C60
compounds with one, two, or three hydrophilic or cat-
ionic groups in combination with white light against
gram-positive bacteria, gram-negative bacteria, and
fungi. After a 10 min incubation, the bis- and tris-cat-
ionic fullerenes were highly active in killing all tested
microbes (4–6 logs) under conditions in which mam-
malian cells were comparatively unharmed. These
compounds performed significantly better than a
widely used antimicrobial photosensitizer, toluidine
blue O. The high selectivity and efficacy exhibited by
these photosensitizers encourage further testing for
antimicrobial applications.
Introduction
Fullerenes (originally buckminsterfullerenes) are a new
class of all-carbon molecules; the first example was dis-
covered by Kroto et al. in 1985 [1] and is composed of 60
carbon atoms arranged in a soccer ball-shaped struc-
ture. The condensed aromatic rings present in the com-
pound lead to an extended p conjugation of molecular
orbitals, and this arrangement therefore causes signifi-
cant absorption of visible light. In recent years, there
has been much interest in studying the possible biolog-
ical activities of fullerenes (and other nanostructures
produced in the nanotechnology revolution) with the
*Correspondence: hamblin@helix.mgh.harvard.eduaim of using them in the field of medicine [2–5]. An im-
portant issue when dealing with unmodified fullerenes
is their insolubility in biologically compatible solvents,
limiting their use in biological applications. Therefore,
fullerenes have to be chemically modified or functional-
ized by the introduction of addends in order to acquire
aqueous solubility [6–8].
Interesting biological properties have been reported
for various functionalized fullerenes (reviewed in [2, 5]).
Quarternary functionalized derivatives were found to
inhibit the protease of HIV1 virus [9], while amide-
derivatized fullerenes acted as antiretroviral drugs in
cells [10]. There was a report that a hexakiscarboxylic
acid fullerene derivative prevented death from a group
A Streptococcus infection in mice [11]. Polyhydroxy-
lated fullerenes have been proposed as antioxidants
and free radical scavengers [12–14]. Japanese work-
ers have studied the antibacterial properties of cat-
ionic fullerenes as inhibitors of bacterial respiration
[15–17] (see following sections).
The combination of absorption of visible light by fuller-
enes, referred to above, and a long-lived triplet state
allows fullerenes to act as photosensitizers (PS). In a sim-
ilar fashion to the tetrapyrrole PS used for photodynamic
therapy (PDT) [18], illumination of solubilized fullerenes
in the presence of oxygen leads to the generation of re-
active oxygen species (ROS) via energy transfer from
the excited triplet state of the fullerene to molecular oxy-
gen. A recent report [19] has shown that in polar solvents,
especially those containing reducing agents (such as
NADH, found in cells), illumination will generate the re-
duced oxygen species, superoxide anion and hydroxyl
radical, while in nonpolar solvents, singlet oxygen is
the main product. These different pathways are analo-
gous to the Type II and Type I photochemical mecha-
nisms frequently discussed in PDT with tetrapyrroles
[18]. Fullerenes have been used to carry out in vitro
PDT, leading to cleavage of DNA strands [20], photoinac-
tivation of viruses [21], a demonstration of mutagenicity
in Salmonella species [22], and photo-induced killing of
mammalian cells in tissue culture [23]. There has also
been a report of fullerene-mediated PDT resulting in
cures in a murine subcutaneous tumor model [24].
Although PDT was originally discovered over 100
years ago by its effect on killing microorganisms [25],
it was largely developed as a cancer therapy [26] and
recently has achieved great success as a treatment for
age-related macular degeneration [27]. The possible
use of PDT as a treatment for localized infections due
to its antimicrobial potential is only just being seriously
investigated [28–30]. It has been known for some time
that PS molecules that bear one or more net cationic
charges perform best as antimicrobial PS compared
to neutral or anionic structures [31–33]. The positive
charges allow the PS to bind to the negative charges
borne by most microbial cells, and, in the case of
gram-negative bacteria, the cationic charges weaken
the permeability barrier of the outer membrane struc-
ture, allowing the PS to penetrate to more sensitive in-
tracellular locations [30, 34].
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timicrobial photodynamic activities of two series of
functionalized C60; a first series with one, two, or three
polar diserinol groups (BF1–3), and a second series
with one, two, or three quarternary pyrrolidinium groups
(BF4–6). Gram-positive bacteria, gram-negative bacte-
ria, and fungi were tested, and the photodynamic killing
was compared with that mediated by a widely used an-
timicrobial PS, toluidine blue O (TBO). Finally, the extent
to which the photoactivated C60 derivatives allowed
selective killing of microbes while sparing mammalian
cells was assessed.
Results
Synthesis and Characterization of Functionalized
Fullerenes
BF1–3 and BF4–6 were synthesized according to mod-
ifications of established literature procedures [35–38] as
shown in Figures 1 and 2. There are 8 possible re-
gioisomers of the bis-substituted fullerenes and 46 pos-
sible regioisomers of the tris-substituted fullerenes, and
it was not practical to separate these mixtures of
regioisomers into individual pure compounds; there-
fore, BF2, BF3, BF5, and BF6 were studied as mixtures
of regioisomers. The identity of the compounds, how-
ever, was confirmed by mass spectrometry, giving mo-
lecular ions identical to those calculated. The proton
and C13 NMR spectra of the immediate precursors of
BF1 and BF4 have been previously reported [35, 37].
The absorption spectra of BF4–6 and TBO, all at the
same concentration of 10 mM in DMSO:water (1:9),
are shown in Figure 3. The overall extinction coeffi-
cients of the fullerenes were in the following order:
BF4 > BF5 > BF6. The shoulder in the UVA range
moved from 340 nm for BF4 to 310 nm for BF5 and
disappeared altogether for BF6.
Initial Screening of Functionalized Fullerenes
as Antimicrobial PS
We initially screened the fullerenes BF1–6 to assess
their potential to mediate photodynamic inactivation
(PDI) against the gram-positive S. aureus after 10 min in-
cubations with 100 mM concentrations and no wash.
Compounds BF5 and BF6 were completely dark toxic
to S. aureus and gave zero colonies or >99.9999% kill-
ing regardless of the amount of light delivered (data
Figure 1. Synthesis of BF1–3
(i) 200ºC, 45 min. (ii) Acetic anhydride, pyridine, 18 hr. (iii) CBr4,
DBU, acetone, toluene, 4.5 hr. (iv) K2CO3, methanol, H2O. Et, ethyl;
Ac, acetyl; DBU, 1,8-Diazabicyclo[5.4.0]undec-7-ene.not shown). Compound BF4 showed significant dark
toxicity (99%; see first point of curve with squares in
Figure 5). Compounds BF1–3, however, showed only
minor dark toxicity toward S. aureus (60%–80%;
see Figure 4A). When relatively large fluences of
broad-band white light were delivered to bacterial sus-
pensions still containing the fullerenes, a fluence-
dependent loss of viability of S. aureus ranging from
2–4 logs of killing, as shown in Figure 4A (closed sym-
bols), was observed. BF1–3 displayed significant differ-
ences in effectiveness between members of the series.
Their effectiveness was BF3 > BF2 > BF1, and the differ-
ences in the survival fraction were significant (p < 0.05)
at the two highest fluences (80 and 120 J/cm2).
In order to test whether the fullerenes actually bound
to the bacterial cells, we compared PDI with and without
a wash (centrifugation of the suspension containing the
fullerene and resuspension in fresh PBS). As can be
seen by comparing curves with open and closed sym-
bols in Figure 4A, there was no difference in killing with
and without a wash, showing that the fullerenes bound
to the bacteria and could not easily be washed out.
We tested BF1–3 under the same conditions (100 mM
incubation for 10 min and no wash) with the gram-neg-
ative E. coli. As shown in Figure 4B, there was no dark
toxicity and only a very small amount of light-mediated
killing (less than 90%). BF1 was significantly less effec-
tive than BF2–3 (p < 0.05).
Figure 2. Synthesis of BF4–6
Figure 3. UV-Visible Absorption Spectra of BF4–6 and TBO at
10 mM in 1:9 DMSO:Water
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1129Figure 4. PDI of Bacteria with BF1–3
(A) S. aureus (108 cells per ml) were incubated for 10 min with BF1–3 at a 100 mM concentration in PBS, followed, or not, by a wash (centri-
fugation and resuspension) and illumination with 400–700 nm light at an irradiance of 200 mW/cm2. Aliquots were removed from the suspen-
sions after the various fluences of light had been delivered and the CFU had been determined. Values are means of six independent
experiments, and bars are SEM. *p < 0.05; **p < 0.01; two-tailed unpaired t test.
(B) E. coli (108 cells per ml) was treated the same as S. aureus.Cationic Fullerenes Mediate Photodynamic
Inactivation of Three Microbial Classes
Compound BF4 showed significant dark toxicity toward
S. aureus at 100 mM, and we therefore decreased the
concentration of BF4 in the incubation mixture in a step-
wise manner to 50, 25, 10, and 1 mM. These experiments
were carried out with a wash. As shown in Figure 5, the
dark toxicity decreased as the concentration was
decreased until, at 10 and 1 mM, it was nonexistent.
When PDI experiments were carried out after incuba-
tion of S. aureus with these concentrations of BF4, a flu-
ence-dependent loss of viability was observed in all
Figure 5. PDI of S. aureus with BF4
S. aureus at 108 cells per ml was incubated with the specified con-
centrations of BF4 for 10 min, followed by a wash and illumination
with white light. Values are means of six independent experiments,
and bars are SEM.cases with comparatively low doses of light (4–8 J/cm2).
Remarkably, the PDI killing curves were not significantly
different (compare the slopes of curves in Figure 5)
among the different concentrations. The difference be-
tween the curves was solely in the survival fraction at
0 J/cm2, i.e., the dark toxicity.
Since the initial screening experiment had suggested
that the bis- and tris-cationic fullerenes BF5 and BF6
would be more potent than BF4 (higher dark toxicity),
we tested them against S. aureus at 1 mM with a wash.
As shown in Figure 6A, compounds BF5 and BF6
were highly active, with 2 and 1 J/cm2 of light being
sufficient to kill 4–5 logs, respectively; all three killing
curves were significantly different (p < 0.01).
As it is well known that gram-positive bacteria are
much more susceptible to PDI than gram-negative bac-
teria or fungal species [39, 40], we decided to test the
cationic fullerenes BF4–6 at 10 mM with a wash against
the other microorganisms. Figure 6B shows the light-
mediated killing of gram-negative E. coli with the three
cationic fullerenes. BF5 and BF6 were highly effective,
with 2 J/cm2 giving 4 and 6 logs of killing, respectively.
BF4 was much less potent, needing 8 J/cm2 to give 3
logs of killing (p < 0.001). There was only minimal dark
toxicity. Similar results were obtained with the yeast
C. albicans (Figure 6C), in which BF6 was slightly
more effective than BF5 and both were much better
than BF4 (p < 0.001). The gram-negative bacterium
P. aeruginosa was more resistant than the other organ-
isms tested (Figure 6D). We doubled the maximum light
dose delivered to 16 J/cm2 in order to obtain more kill-
ing, but this had only a minimal effect. BF5 and BF6
were able to kill 3–5 logs, while BF4 only gave 2 logs
of killing of P. aeruginosa.
Comparison of BF4–6 and Toluidine Blue
O-Mediated PDI of E. coli in the Presence of Serum
In order to obtain an objective measure of how cationic
fullerenes performed as antimicrobial photosensitizers,
we compared them with a widely used phenothiazinium
Chemistry & Biology
1130Figure 6. PDI of Bacteria and Yeast with BF4–6
(A–D) (A) S. aureus was incubated with a 1 mM concentration of BF4–6, and (B) E. coli, (C) C. albicans, and (D) P. aeruginosa, all at 108 cells per
ml, were incubated with BF4–6 at 10 mM concentrations for 10 min, followed by a wash and illumination with white light. Values are means of
six independent experiments, and bars are SEM. *p < 0.05, **p < 0.01, ***p < 0.001; two-tailed unpaired t test.dye. However, in order to be able to directly compare
the PDI-mediated killing of bacteria with PDT killing of
mammalian cells, we needed to add 10% serum to the
bacterial suspension, as this is the standard growth
condition for fibroblasts. It has previously been shown
that the addition of serum to bacterial PS incubations
significantly reduces the effectiveness, probably be-
cause the PS binds to serum proteins, thus reducing
the effective concentration available to bind to bacteria
[41, 42]. We therefore tested the PDI of E. coli by using
BF4–6 and TBO under the same conditions (10 mM,
10 min incubation in the presence of 10% FBS and
a wash). As shown in Figure 7A, TBO was almost inef-
fective in mediating PDI. When the BF4–6-mediated kill-
ing was compared with that shown in Figure 6B (no
serum), it can be seen that the effectiveness of BF4
was unchanged, while the killing mediated by BF5 and
BF6 was reduced by about 1 log in the presence of se-
rum. TBO at the same concentration and fluence as was
used for fullerenes (1 mM for S. aureus and 10 mM for
both P. aeruginosa and C. albicans) produced less
than 1 log of killing in the presence or absence of serum
(data not shown).
Cationic Fullerenes Show Selectivity for Microbes
over Mammalian Cells
In order to assess the selectivity of light-mediated killing
for microbes over mammalian cells, we incubated
mouse L929 fibroblasts with BF4–6 and with TBO under
the same conditions (10 mM concentration for 10 min in
10% FBS and a wash), followed by delivery of white or
red light, respectively, up to 120 J/cm2. BF4–6 did
show some dark toxicity (20%–60% killing) and someadditional phototoxicity (20%–30%) toward L929 cells,
as shown in Figure 7. However, TBO displayed a differ-
ent shape of killing curve with little dark toxicity, but
a pronounced light-dependent toxicity, until the limit
of the viability assay was reached at 80 J/cm2.
Discussion
The effectiveness of various PS proposed for antimicro-
bial PDT can be judged on several criteria. These PS
should be able to kill multiple classes of microbes at rel-
atively low PS concentrations and low fluences of light.
PS should be reasonably nontoxic in the dark and
should demonstrate selectivity for microbial cells over
mammalian cells. PS should ideally have large extinc-
tion coefficients in the red part of the spectrum and
demonstrate high triplet and singlet oxygen quantum
yields. In this report, we have shown that cationic fuller-
enes fulfill many (but not all) of these criteria. The main
disadvantage of using fullerenes as antimicrobial PS
lies in their absorption spectrum. As shown in Figure 3,
the fullerenes have broad absorption in the UV range,
with a tail that extends well into the visible spectrum
(to 550 nm in the case of BF4). The UV absorption de-
creased as the number of substituents on the fullerene
increased, and, consequently, the degree of p conjuga-
tion decreased. TBO, however, like many other PS used
for PDT and PDI, has an absorption peak in the red at
635 nm. Many reports show that PDT in vivo is more ef-
fective with red light and near infrared light, as both the
absorption and scattering of light by tissue decrease as
the wavelength increases [43]. We used a broad-band
pass filter that gives an output of the entire visible
Antimicrobial PDT with Cationic Fullerenes
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(A) E. coli was incubated with a 10 mM concentration of BF4–6 or TBO in the presence of 10% FBS for 10 min, followed by a wash and illu-
mination with white or red light, respectively.
(B) L929 murine fibroblasts at 80% confluence were incubated with BF4–6 or TBO, both at a 10 mM concentration, for 10 min in the presence of
10% FBS, followed by a wash and illumination with white or red light. The survival fraction was calculated by using the MMT viability assay.
Values are means of six independent experiments, and bars are SEM.spectrum (400–700 nm) to excite the fullerenes that
maximized the absorption by the tail in the visible range.
We did not use UV light to excite the fullerenes, as UV
light is highly germicidal and can kill most microorgan-
isms. As can be seen from Figure 3, the effective ab-
sorption of the delivered wavelength ranges was not
very different between the fullerenes and TBO.
Our initial screening experiment carried out against
S. aureus at a 100 mM concentration showed that the
C60 substituted with pyrrolidinium groups behaved
very differently than the series substituted with di-seri-
nol groups. The cationic fullerenes gave high levels of
dark toxicity (except for BF4), while the di-serinol-func-
tionalized C60 showed a typical light dose-dependent
loss of colony-forming ability. However, cationic fuller-
enes were highly effective PS at lower concentrations.
This finding agrees with numerous reports in the litera-
ture that demonstrate that PS with one (or preferably
more) cationic group are efficient antimicrobial PS [30,
31, 33, 44, 45]. Quarternary nitrogen-based groups are
superior to primary, secondary, or tertiary amino
groups, as the positive charge is less dependent on
the pH of the surrounding media, or the pKa of the
molecules that the PS is interacting with. Microbial cells
possess overall negative charges, and it is thought that
cationic PS bind to these groups on the outer layers of
the cell surface. Gram-positive and fungal cells have rel-
atively permeable outer layers of peptidoglycan and lip-
oteichoic acid or b-glucan, respectively, although the
mannan layer of Candida species can present a perme-
ability barrier. This allows cationic, and to a lesser ex-
tent, noncationic PS to diffuse inward to the plasma
membrane, where the generation of reactive oxygen
species under illumination can damage the membrane
structure, allowing for leakage of essential components
and causing cell death. Our finding that BF1–3 were
equally effective against the gram-positive S. aureus
with and without a wash demonstrates that the neutrally
charged fullerenes were indeed able to penetrate to
a sufficient extent into the cell and that they could not
easily be washed out. By contrast, gram-negative bac-
teria have a double membrane structure that presentsa barrier to diffusion of many PS. Cationic compounds
are able to displace divalent cations (Ca21 and Mg21)
that play a role in the attachment of lipopolysaccharide
to the outer membrane [46]. This displacement weakens
the structure of the outer permeability, allowing the PS
to penetrate further in a process that has been termed
‘‘self-promoted uptake’’ [47]. The fact that this mecha-
nism requires cationic compounds explains why BF1–3
were relatively ineffective against the gram-negative
E. coli, and such findings have been reported with nu-
merous other noncationic PS [30].
Because the neutral, alcohol-functionalized fullerenes
(BF1–3) had only modest activity against S. aureus, we
decided to concentrate our efforts on the cationic pyrro-
lidinium-functionalized fullerenes (BF4–6). These com-
pounds (especially BF5 and BF6) demonstrated high
levels of dark toxicity against S. aureus. This finding is
in agreement with reports by Mashino et al. [15, 16,
48]. These workers proposed that cationic fullerenes
could inhibit the growth of E. coli and S. aureus by inter-
fering with the respiratory chain. There was a biphasic
dose response, with the fullerenes inhibiting oxygen up-
take at low concentrations and increasing oxygen con-
sumption at high concentrations with concomitant
production of hydrogen peroxide. However, we found
that at concentrations that gave only low values of
dark toxicity, BF4–6 were surprisingly effective in caus-
ing light-mediated killing of S. aureus. BF5 and BF6
needed only a 1 mM concentration and 1 or 2 J/cm2 of
white light to kill 4–5 logs. BF4 showed unusual behavior
in mediating PDI of S. aureus. At 100 mM, there were 2
logs of dark toxicity and an additional 2 logs of light-
mediated killing. As the concentration of BF4 was
decreased, the dark toxicity decreased as expected.
However, we were surprised to observe that the slope
of the light-dependent killing curves were similar for
the range of concentrations (although the slope for 1
mM BF4 was somewhat less; see Figure 5). It would
have been expected that the slopes would decrease
as the concentration of fullerene able to produce reac-
tive oxygen upon illumination decreased. This finding
suggests that the binding of BF4 is largely independent
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a fairly low BF4 concentration. Alternatively, this phe-
nomenon may be due to the relatively poor solubility
of BF4 that may cause the molecule to be aggregated
in aqueous solvents at high concentrations and that
would lead to its binding to bacteria being limited by
aggregation.
BF4–6 were tested against E. coli at 10 mM, and BF5
and BF6 showed similar high levels of activity, giving
4–6 logs of killing after 2 J/cm2. The fact that these lev-
els of killing were obtained with a wash showed that the
fullerenes bound firmly to the gram-negative cells, as
has been found with other cationic PS [45]. BF5
and BF6 were equally effective against C. albicans at
10 mM with a wash. Although C. albicans does not
have the permeability barriers associated with gram-
negative bacteria, the eukaryotic cells are very much
larger than bacteria [45]. This means that there is corre-
spondingly more membrane and proteins per cell to re-
act with the reactive oxygen species produced by
illuminated fullerenes, and, consequently, a higher con-
centration is necessary to achieve killing compared to
the smaller S. aureus. P. aeruginosa is known to have
even more efficient permeability barriers than the major-
ity of other gram-negative species [49, 50]. Although 10
mM BF5 and BF6 with a wash did give 4–5 logs of killing,
it was necessary to use significantly more light (up to 16
J/cm2) compared to what was used with E. coli. Al-
though BF6 was generally more effective than BF5 in
killing all species, the difference between these two
compounds was much smaller than the difference be-
tween BF4 and BF5. The addition of extra pyrrolidinium
groups to the fullerene backbone decreases the ab-
sorption of light (see Figure 3) and hence reduces the ef-
ficiency of photoinactivation per photon delivered.
Presumably, the addition of a third cationic group to
the fullerene molecule increased the binding and/or
penetration into the cells sufficiently to do more than
compensate for the reduced light absorption.
In order to make comparisons between the effective-
ness and selectivity of the cationic fullerenes with an
established antimicrobial PS, we studied the phenothia-
zinium dye TBO under the same conditions. TBO has
been widely used to kill multiple classes of microbes
in vitro after illumination with red light [51–55]. It has
also been tested in several animal models of localized
infections. Wong et al. [56] used topical TBO and red
light to cure an otherwise fatal wound infection with
Vibrio anguillarum in mice, Komerik et al. [57] used
TBO and light to treat a rat model of periodontal infec-
tion, and Teichert et al. [58] used the closely related
phenothiazinium dye methylene blue combined with
light to treat a mouse model of oral candidiasis. In our
studies, TBO (under the same conditions as cationic
fullerenes, i.e., 1 or 10 mM, 10 min incubation, and up
to 16 J/cm2 of red light) did not kill more than 90% of
any of the microbial species. Therefore, BF5 and BF6
are many orders of magnitude more effective than
TBO, a widely used antimicrobial PS.
If it is proposed to employ antimicrobial PS to treat
localized infections in animals or patients, it is neces-
sary to address the question of selectivity of the PS
for microbial cells as compared to host mammalian
cells. One reason why this selectivity may be relativelyeasy to demonstrate is that antimicrobial PDI is often
carried out with relatively short incubation times (mi-
nutes) before illumination. By contrast, mammalian cells
in tissue culture are frequently incubated with PS for pe-
riods of hours (even 24 hr). Hence, if killing is compared
between microbes and mammalian cells after a short
incubation time, it is likely to favor microbial killing. An-
other difficulty in comparisons between killing microbes
and mammalian cells depends on the difference in via-
bility assays. The CFU assay for microorganisms can
detect 6 logs of killing, while the MTT assay for mamma-
lian cell viability has a maximum detection limit of 2 logs
of killing. Nevertheless, it is clear from the data in the
present report that the fullerenes show a greater level
of selectivity for microbes over mammalian cells than
is observed for TBO under the same conditions. Soukos
et al. reported that 16 mM TBO and red light selectively
killed Streptococcus sanguis compared to oral keratino-
cytes and fibroblasts after a 5 min incubation [53].
It is at present uncertain whether the mechanism of
microbial inactivation with photoactivated fullerenes
involves singlet oxygen (Type 2 mechanism) or su-
peroxide and hydroxyl radicals (Type 1 mechanism).
Yamakoshi et al. reported that, while fullerenes were
efficient generators of singlet oxygen upon illumination
in organic solvents, in biological systems that include
reductants, such as NADH, the mechanism shifted to
Type 1 [19]. Another consideration is the ability of fuller-
enes to act as antioxidants or scavengers of ROS in
cells [59, 60]. If fullerenes are able both to generate
ROS and to scavenge ROS at the same time, it could
be asked which process is more important in antimicro-
bial PDI, since they appear to be competing against one
another. Another consideration is the fact that the bis-
and tris-functionalized fullerenes were used as mixtures
of regioisomers. Hamono et al. [61] have shown that, not
only the number of substituents on the fullerene, but
also the relative positions of the substituents, may af-
fect the photochemical production of reactive oxygen
species. Future work should endeavor to determine
which of the possible regioisomers of BF5 and BF6
are most active as antimicrobial PS. In conclusion, we
have shown that bis- and tris-cationic fullerenes are
highly active antimicrobial PS that mediate the destruc-
tion of a broad spectrum of microbial classes and show
better selectivity for microbes over mammalian cells
than TBO, a widely used antimicrobial PS. We believe
that cationic fullerenes deserve further investigation as
antimicrobial PS, particularly in those situations in
which red light activation is not important for the light
to penetrate deep into tissue.
Significance
The relentless world-wide increase in antibiotic resis-
tance among multiple classes of pathogens has led to
a search for alternative antimicrobial therapies. There
has coincidentally been a search for biological and
medical applications of fullerenes since their discov-
ery 20 years ago, and, more recently, there has been
a major effort to uncover biological applications of
nanotechnology. For the first time, to our knowledge,
we have demonstrated that cationic fullerenes with
one, two, or three pyrrolidinium groups, after a short
Antimicrobial PDT with Cationic Fullerenes
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have a broad-spectrum antimicrobial activity and can
rapidly kill more than 99.99% of bacterial and fungal
cells. Although the light absorbance decreases with
increased cationic substitution, the increasing posi-
tive charge allows the fullerenes to bind to cells and
overcome microbial permeability barriers. Cationic
fullerenes perform better as antimicrobial photo-
sensitizers than the widely employed antimicrobial
photosensitizer toluidine blue O. Cationic fullerene-
mediated photodynamic therapy may have a role to
play in the treatment of localized infections in such
areas as wounds, burns, skin, and mucus membranes.
Experimental Procedures
Synthesis and Characterization of Functionalized Fullerenes
All chemicals were purchased from Aldrich Chemical Co. (Mil-
waukee, WI) and were used without further purification unless stated
otherwise.
Synthesis of BF1, BF2, and BF3
This synthesis was carried out by using methods previously de-
scribed in the literature [35, 36], with some modifications, as shown
in Figure 1. Serinol (2.05 equivalents) and diethylmalonate (1 equiv-
alent) were reacted at 200ºC for 45 min in an open tube. Then, acetic
anhydride (4.1 equivalents) and pyridine (4.1 equivalents) were
added, and the solution was stirred for 18 hr at room temperature.
The product termed MSA thus obtained was recrystallized by using
a mixture of hexanes and ethyl acetate.
C60 (99.5% purity) was purchased from SES Research, Houston,
TX. C60 (220 mg, 0.31 mmol) was dissolved in toluene (250 ml) by
sonicating for 2 hr. The solution was filtered, and nitrogen was
purged for 30 min. Then, CBr4 (46.1 mg, 0.14 mmol) as a solid,
MSA (58.2 mg, 0.14 mmol) in acetone (3 ml), and 1,8-diazabicy-
clo[5.4.0]undec-7-ene (31.7 mg, 0.21 mmol) in toluene (5 ml) were
added. The reaction mixture was stirred at room temperature for
4.5 hr under a nitrogen atmosphere. Solvents were removed under
vacuum. The product was dissolved in a minimum amount of chlo-
roform and loaded onto a silica gel column (1 in 3 9 in) and eluted
with dichloromethane containing 0%–2% methanol to collect
pure –OH-protected BF1, BF2, and BF3 (order of elution is C60-
MSA, C60-MSA2, and, finally, C60-MSA3). The protected com-
pounds were characterized by matrix-assisted laser desorption
ionization mass spectrometry (MALDI-MS). C60-MSA, calculated
mass 1137.02 and observed mass 1137.56; C60-MSA2,
calculated mass 1553.40 and observed mass 1553.77; C60-MSA3,
calculated mass 1969.78 and observed mass 1970.26. NMR data
were obtained for C60(MSA)-protected BF1:
1H NMR (400 MHz,
CDCl3, TMS ref.) d (ppm) 2.10 (s, 12H, CH3), 4.34–4.41 (m, 8H, CH2),
4.68–4.72 (m, 2H, CH), 7.37 (br d, J5 6.4 Hz, 2H, NH).
Deprotection of -OH groups was achieved by treating C60-MSA1–3
with excess amounts of potassium carbonate in methanol and
deionized water at room temperature for 90 min. Potassium ions
were removed by adding strong cation exchange resin (Biorad
AG MP-50W, treated with 1 M HCl) to the reaction mixture until
the pH reached 7. The solution was filtered, and solvents were
removed to obtain pure BF1, BF2, and BF3.
Synthesis of BF4, BF5, and BF6
This synthesis was carried out by using methods previously de-
scribed in the literature [37, 38], with some modifications, as shown
in Figure 2. The pyrrolidinium group is referred to as NMP in this
synthesis. To a C60 solution (described above), sarcosine (50.8 mg,
0.57 mmol) and paraformaldehyde (40.9 mg, 1.36 mmol) for C60-
NMP, sarcosine (62.5 mg, 0.70 mmol) and paraformaldehyde (21.5
mg, 0.71 mmol) for C60-NMP2, or sarcosine (125.0 mg, 1.4 mmol)
and paraformaldehyde (43.0 mg, 1.43 mmol) for C60-NMP3, as solids
directly, were added. The reaction mixture was refluxed for 2 hr for
C60-NMP and overnight for C60-NMP2 and C60-NMP3. Solvents were
reduced under vacuum. The solution was loaded onto a silica gel
column (1 in 3 9 in) packed with toluene and eluted with toluenecontaining 0%–5% acetone to collect pure C60-NMP, C60-NMP2,
or C60-NMP3 with yields of 30%–40%. The purity of the compounds
in terms of mono-, bis-, and tris-substitutions was confirmed by
thin-layer chromatography (TLC). Methylation of C60-NMP, C60-
NMP2, or C60-NMP3 was carried out by dissolving the compounds
in a large excess of methyl iodide (1 ml per 20 mg C60-NMPn) and
stirring for 48 hr at room temperature (7 days in the case of C60-
NMP3). Pure methylated product BF4, BF5, and BF6 were precipi-
tated by adding hexanes, and the precipitates were collected,
washed with toluene and dichloromethane, and dried. The com-
pounds were characterized by electrospray mass spectrometry
(ES-MS). BF4, calculated mass 792.08 and observed mass 792.04;
BF5, calculated mass 864.16 and observed mass 432.05 (M21);
BF6, calculated mass 936.24 and observed mass 312.08 (M31).
NMR data were obtained for BF4: 1H NMR (400 MHz, 2:3
CDCl3:DMSO-d6, TMS ref.) d (ppm) 4.08 (s, 6H, CH3), 5.72 (s, 4H,
CH2). UV-visible absorption spectra (Figure 3) of the compounds
were recorded in 1:9 DMSO:water at a concentration of 10 mM.
Microbial Strains and Culture Conditions
Staphylococcus aureus (ATCC #35556), Escherichia coli (ATCC
#25922), and Pseudomonas aeruginosa (ATCC #BAA-47; PAO1)
were cultured in brain-heart infusion (BHI) broth (Difco, BD Diagnos-
tic Systems, Sparks, MD) at 37ºC in aerobic conditions in a shaker at
150 rpm. Candida albicans (ATCC #18804) was grown in YM broth
(Difco). Exponential cultures obtained by reculturing stationary
overnight precultures were used for all experiments. E. coli, P.
aeruginosa, and S. aureus were grown in fresh medium for approx-
imately 1 hr to a density of 108 cells/ml; the OD values at 650 nm
were 0.6, 0.8, and 0.8, respectively. C. albicans was grown for ap-
proximately 4 hr to an approximate density of 108 cells/ml, corre-
sponding to an OD of 6 at 650 nm (10-fold dilution measured).
Cells were used for experiments in the mid-log growth phase.
Photosensitizers and Light Source
Toluidine blue O was purchased from Sigma (St. Louis, MO) and was
dissolved in water to give a 1 mM stock solution that was stored in
the dark at 4ºC for a maximum of 2 weeks. We used a noncoherent
lamp with filtered liquid light guides (LumaCare LC122, MBG Tech-
nologies, Inc., Newport Beach, CA) to provide illumination. For illu-
mination of fullerenes, we used a broad-band white light band pass
filter (400–700 nm), and, for TBO, we used a band pass filter at 620–
650 nm. The lamp was adjusted to give a uniform spot of 4 cm diam-
eter with an irradiance of 200 mW/cm2, as measured with a power
meter (model DMM 199 with 201 Standard head, Coherent, Santa
Clara, CA).
Photodynamic Inactivation Studies
We dissolved the fullerenes in DMSO to give 5 mM solutions (com-
pound BF4 was poorly soluble; therefore, the concentration of the
stock solution was 2.7 mM) and stored them in the dark at room
temperature. In the initial screening experiments, we used suspen-
sions of S. aureus cells (108 per ml) incubated with fullerenes BF1–6
at a concentration of 100 mM in PBS at room temperature for 10 min.
In subsequent experiments, the bacterial suspension was centri-
fuged (4000 3 g for 10 min) after incubation and resuspended
in fresh PBS before illumination; this procedure is referred to as
a wash. E. coli, P. aeruginosa, and C. albicans were used at concen-
trations of 108 cells per ml. Illumination was carried out from above
with cell suspensions in wells of a 24-well plate, and aliquots were
removed at times corresponding to the delivery of calculated fluen-
ces of light. These aliquots were serially diluted in PBS and streaked
on square BHI or YM agar plates according to the method of Jett
et al. [62]. Survival fractions were calculated with reference to cells
incubated in PBS alone, and values on killing curves at 0 J/cm2 rep-
resent the dark toxicity of the fullerenes. Cells treated with light and
no photosensitizer did not show any loss of viability.
Mammalian Cell Culture Experiments
L929 murine fibroblasts (ATCC #CCL1) are a spontaneously trans-
formed immortalized cell line established from the normal subcuta-
neous areolar and adipose tissue of a male C3H/An mouse [63]. The
cells were cultured in Dulbecco’s modified Eagle’s medium (Sigma)
at 37ºC in a humidified atmosphere containing 5% CO2. The medium
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1134was modified by using 4 mM L-glutamine (containing 1.5 g/l sodium
bicarbonate and 4.5 g/l glucose), 10% fetal bovine serum (FBS),
100 U/ml penicillin, and 100 mg/ml streptomycin. Cells were plated
in 96-well cell culture plates, at a density of 300 cells/well, and
were allowed to attach for 24 hr. Fullerenes or TBO were added at
a concentration of 10 mM in 200 ml complete medium per well. After
10 min, fresh medium was added, followed by illumination with
white light (for fullerenes) or red light (for TBO). At the completion
of the illumination, cells were returned to the incubator for 24 hr.
Cell viability was determined by using the MTT-microculture tetra-
zolium assay, a method of assessing cellular response to PDT
[64]. This assay involves the reduction of a colorless substrate (3-
[4,5-Dimethylthiazol-2-yl]-diphenyltetrazolium bromide; Sigma) to
an insoluble dark-blue formazan product, which is formed in pro-
portion to the amount of succinate dehydrogenase activity in the mi-
tochondria of living cells. After incubation with MTT for periods
ranging from 4 to 8 hr, the medium was aspirated off each well,
and 100 ml DMSO was added; the absorbance at 570 nm was read
by a microplate reader (Spectra Max 340 PC, Molecular Devices,
Sunnyvale, CA). The fraction of cells surviving was calculated by di-
viding the mean absorbances of formazan produced from PDT-trea-
ted cells by the mean absorbances from dark controls incubated
with PS and kept at room temperature for periods equal to irradia-
tion times.
Statistics
Values are given as means and standard errors of at least six inde-
pendent wells. Differences between killing curves were tested for
significance at the highest comparable fluence by an unpaired
two-tailed Student’s t test, assuming equal or unequal variation in
the standard deviations as appropriate. P values of less than 0.05
were considered significant.
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